We are live on ! Find out more
HF

HRT Financial Portfolio holdings

AUM $40.1B
1-Year Est. Return 58.22%
This Fund
S&P 500
This Quarter Est. Return
+7.61%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$10.9B
AUM Growth
+$1.02B
Cap. Flow
+$744M
Cap. Flow %
6.82%
Top 10 Hldgs %
30.62%
Holding
3,895
New
1,275
Increased
565
Reduced
595
Closed
1,134

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Healthcare 9.21%
3 Consumer Discretionary 8.28%
4 Industrials 6.28%
5 Materials 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIH
2526
DELISTED
Aesthetic Medical International Holdings
AIH
$133K ﹤0.01%
16,764
+437
+3% +$3.26K
CWBR
2527
DELISTED
CohBar, Inc. Common Stock
CWBR
$133K ﹤0.01%
+3,177
New +$125K
RMGB
2528
DELISTED
RMG Acquisition Corp. II Class A Ordinary Shares
RMGB
$133K ﹤0.01%
13,434
+247
+2% +$2.46K
PAVS icon
2529
Paranovus Entertainment Technology
PAVS
$5.94M
0
RTL
2530
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
$132K ﹤0.01%
15,599
-9,679
-38% -$90.3K
LGAC
2531
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
$131K ﹤0.01%
+13,477
New +$132K
QTT
2532
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$129K ﹤0.01%
6,959
+1,430
+26% +$30.2K
FOCL
2533
EDAP TMS S.A.
FOCL
$229M
$128K ﹤0.01%
18,157
-1,064
-6% -$7.72K
TOUR
2534
Tuniu
TOUR
$55.9M
$128K ﹤0.01%
5,418
-1,990
-27% -$54.3K
MRKR icon
2535
Marker Therapeutics
MRKR
$18.7M
$127K ﹤0.01%
+4,557
New +$120K
BRY
2536
DELISTED
Berry Corp
BRY
$125K ﹤0.01%
18,644
-3,833
-17% -$24.3K
MEUSW
2537
DELISTED
23andMe Holding Co Warrant
MEUSW
$125K ﹤0.01%
+41,542
New +$83.1K
ADMA icon
2538
ADMA Biologics
ADMA
$2.33B
$124K ﹤0.01%
77,941
+12,177
+19% +$21.4K
AUVI
2539
DELISTED
Applied UV, Inc. Common Stock
AUVI
$124K ﹤0.01%
+101
New +$117K
SCPH
2540
DELISTED
scPharmaceuticals
SCPH
$123K ﹤0.01%
+20,261
New +$122K
UCL
2541
uCloudlink Group
UCL
$27.5M
$123K ﹤0.01%
12,317
+892
+8% +$9.85K
AMRN
2542
Amarin Corp
AMRN
$301M
$122K ﹤0.01%
+1,395
New +$137K
ELA icon
2543
Envela
ELA
$468M
$122K ﹤0.01%
+25,482
New +$116K
VKTX icon
2544
Viking Therapeutics
VKTX
$3.88B
$122K ﹤0.01%
+20,484
New +$122K
AEHL icon
2545
Antelope Enterprise Holdings
AEHL
$5.56M
$121K ﹤0.01%
17
APRE icon
2546
Aprea Therapeutics
APRE
$7.83M
$121K ﹤0.01%
1,245
-2,434
-66% -$225K
RMCO icon
2547
Royalty Management
RMCO
$36.2M
$121K ﹤0.01%
+12,200
New +$121K
MBT
2548
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$121K ﹤0.01%
13,084
-10,188
-44% -$90.5K
DVAX
2549
DELISTED
Dynavax Technologies
DVAX
$120K ﹤0.01%
12,281
-154,488
-93% -$1.4M
PSFE.WS
2550
DELISTED
Paysafe Ltd Warrants
PSFE.WS
$120K ﹤0.01%
33,781
-1,077
-3% -$4.11K

Similar funds

HRT Financial's Q2 2021 Portfolio in Review

As of Q2 2021, HRT Financial held 3,895 positions worth $10.9B, up 10% from $9.88B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

HRT Financial deployed $744M of net new capital in Q2 2021, opening 1,275 new positions and adding to 565 existing holdings. Its largest new stake was Linde: 872,603 shares worth $252M.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.1% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $330M trimmed.

  • HRT Financial's largest Q2 2021 buy was Linde: 872,603 shares worth $252M.
  • HRT Financial added most to Invesco QQQ Trust in Q2 2021, an estimated $289M increase.
  • HRT Financial's biggest Q2 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $330M.
  • HRT Financial fully exited Palantir in Q2 2021, selling an estimated $130M.
  • HRT Financial's ten largest holdings make up 31% of its $10.9B portfolio in Q2 2021.
  • HRT Financial opened 1,275 new positions and closed 1,134 in Q2 2021.
  • HRT Financial's portfolio value rose 10% quarter-over-quarter to $10.9B.

Based on HRT Financial's 13F filing for Q2 2021, filed 16 Aug 2021.